Naturally occurring bioactive compounds
https://libcat.nshealth.ca/en/permalink/provcat27186
Mahendra Rai and María Cecilia Carpinella.
(1st ed.)
--Amsterdam, Netherlands:
Elsevier
, 2006.
- Available Online
- View e-Book
- Location
- Online
- Available Online
- View e-Book
- Author
- Rai, Mahendra
- Other Authors
- Carpinella, María Cecilia
- Responsibility
- Mahendra Rai and María Cecilia Carpinella
- Edition
- 1st ed.
- Place of Publication
- Amsterdam, Netherlands
- Publisher
- Elsevier
- Date of Publication
- 2006
- Series Vol.
- v. 3
- Series Title
- Advances in phytomedicine
- ISBN
- 661063680X (electronic bk.)
- Subjects (MeSH)
- Agrochemicals
- Plant Preparations - pharmacology
- Pharmacognosy
- Contents
- Cover -- Contents -- Preface to the series -- Preface -- Chapter 1. Natural compounds as antioxidant and molting inhibitors can play a role as a model for search of new botanical pesticides -- Introduction -- Insecticidal or IGR (insect growth regulator) activity -- Experimental part -- Discussion -- Concluding remarks -- Future perspectives -- Acknowledgments -- References -- Chapter 2. Pesticides based on plant essential oils: from traditional practice to commercialization -- Introduction -- Sources and chemistry of essential oils -- Biological activity -- Commercial products and uses -- Conclusion and future prospects -- Acknowledgment -- References -- Chapter 3. Natural substrates and inhibitors of multidrug resistant pumps (MDRs) redefine the plant antimicrobials -- Introduction -- The quest for natural substrates - rationale -- MDR inhibitors - proof of principle -- MDR mutants and inhibitors valuable tools for natural drug discovery -- A new series of promising plant antimicrobials -- Natural MDR inhibitors from plants -- an increasing body of evidence, 5' methoxyhydnocarpin and synergy in Berberis plants -- Inhibitors against MFS MDRs -- Inhibitors against ABC transporters -- Conclusions and future perspectives -- Acknowledgments -- References -- Chapter 4. New concept to search for alternate insect control agents from plants -- Introduction -- Tannins -- Saponins -- Acknowledgments -- References -- Chapter 5. Role of Melia azedarach L. (Meliaceae) for the control of insects and acari: present status and future prospects -- Introduction -- Phytochemistry -- Laboratory assays -- Conclusion and future prospects -- Acknowledgments -- References -- Chapter 6. Bioactivity of fabaceous plants against food-borne and plant pathogens: potentials and limitations -- Introduction -- Antimicrobial activities of some important fabaceous plants -- Antimicrobials for management of phytopathogens -- Future directions and conclusions -- References -- Chapter 7. Screening of plants against fungi affecting crops and stored foods -- Introduction -- Fungi as contaminants of crops and foods -- History of the use of antifungal compounds -- Interaction of plant products with fungi -- Plant synthesis of light-activated compounds -- Factors affecting plant synthesis of bioactive compounds -- Experimental -- Bioassays -- Plant analysis -- Cell culture analysis -- Isolated compounds -- Assay procedure -- Results and discussion -- Plant extracts -- Cell cultures -- Photoactivity -- Isolated compounds -- Conclusions and future perspectives -- Acknowledgments -- References -- Chapter 8. Opportunities and potentials of botanical extracts and products for management of insect pests in cruciferous vegetables -- Introduction -- Azadirachtin and related products from Azadirachta indica A. Juss -- Spiro enol ether analogues and extracts from Chrysanthemum coronarium L. -- Extracts from Daphne tangutica Maxim. -- Rotenoids and extracts from Derris spp. -- Rotenoids and
- Format
- e-Book
- Location
- Online
The coagulation consult : a case-based guide
https://libcat.nshealth.ca/en/permalink/provcat33434
Alan Lichtin, John Bartholomew, editors.
--New York:
Springer
, c2014.
- Available Online
- View e-Book
- Location
- Online
There have been many changes in the field of coagulation during the past decade. New concepts of epidemiology of risk factors for thrombosis now help clinicians predict who is more likely to form clots after surgery, or after being placed on oral contraceptives. New anticoagulants have the potential to redefine how patients with atrial fibrillation and venous thrombosis are managed. There are new forms of recombinant clotting factors which have changed our approach to hypofibrinogenemia and von…
- Available Online
- View e-Book
- Other Authors
- Lichtin, Alan
- Bartholomew, John R
- Responsibility
- Alan Lichtin, John Bartholomew, editors
- Place of Publication
- New York
- Publisher
- Springer
- Date of Publication
- c2014
- Physical Description
- 1 online resource (xii, 279 pages)
- ISBN
- 9781461495604 (electronic bk.)
- 9781461495598
- Subjects (LCSH)
- Blood coagulation disorders
- Blood - Coagulation
- Hematology
- Oncology
- Abstract
- There have been many changes in the field of coagulation during the past decade. New concepts of epidemiology of risk factors for thrombosis now help clinicians predict who is more likely to form clots after surgery, or after being placed on oral contraceptives. New anticoagulants have the potential to redefine how patients with atrial fibrillation and venous thrombosis are managed. There are new forms of recombinant clotting factors which have changed our approach to hypofibrinogenemia and von Willebrand's disease. Newer antiplatelet agents are available and their use in patients receiving cardiac stents has mushroomed. The management of thrombosis in the setting of pregnancy has changed over the past decade, as well as the way clinicians approach women with multiple miscarriages. An entire new class of compounds, the thrombopoietins, are available to treat individuals with immune thrombocytopenic purpura (ITP). The Coagulation Consult covers major topics of interest to hematologists who are asked to consult on individuals with coagulation related diseases, and encompasses the field's most recent developments. This "case-directed" book describes state-of-the-art approaches to patients with bleeding and clotting disorders, as well as laboratory tests for coagulation. Chapters include different vignettes, focus on typical clinical consult questions, and lay out specific types of treatment. Practicing clinicians being confronted with a coagulation consult, students, residents, fellows and attending physicians will find this unique text an invaluable resource for some of the newer areas of coagulation science, therapy and pharmacology.
- Contents
- 1. Laboratory Analysis of Coagulation -- 2. Easy Bruisability -- 3. Prolonged PT -- 4. Prolonged PTT -- 5. Prolongation of Both PT and aPTT -- 6. Excessive Bleeding with Normal Prothrombin Time, Partial Thromboplastin Time, and Platelet Count -- 7. Diagnosing Thrombocytopenia in the Clinic -- 8. Thrombocytopenia in the Intensive Care Unit and after Solid Organ Transplantation -- 9. Thrombocytosis -- 10. Prolonged Bleeding after Surgery -- 11. The Excessively Clotting Cancer Patient -- 12. Thrombotic Risk factors -- 13. Clotting around Catheters and Other Devices -- 14. Heparin-Induced Thrombocytopenia -- 15. Surgery on Patients on Antiplatelet Agents -- 16. Newer Oral Anticoagulants -- 17. Pregnancy.
- Format
- e-Book
- Location
- Online
Metastatic Bone Disease : An Integrated Approach to Patient Care
https://libcat.nshealth.ca/en/permalink/provcat39684
R. Lor Randall, editor.
(1st ed.)
--New York, NY:
Springer
, c2016.
- Available Online
- View e-Book
- Location
- Online
Providing an integrated approach to the diagnosis and management of patients with metastatic bone disease (MBD), this comprehensive text combines discussion of the pathobiology of the disease with the latest oncological and orthopedic treatment modalities. After opening with an examination of the epidemiology and impact of MBD, the biology of bone metastases are discussed, along with considerations of the tissue of origin. Evaluation, biopsy and medical therapy, including metabolic agents and b…
- Available Online
- View e-Book
- Other Authors
- Randall, R. Lor
- Responsibility
- R. Lor Randall, editor
- Edition
- 1st ed.
- Place of Publication
- New York, NY
- Publisher
- Springer
- Date of Publication
- c2016
- Physical Description
- 1 online resource (xiii, 368 p. : 85 illus., 35 illus. in color)
- ISBN
- 9781461456629
- 9781461456612 (print ed.)
- Subjects (MeSH)
- Bone Neoplasms - secondary
- Bone Neoplasms - therapy
- Abstract
- Providing an integrated approach to the diagnosis and management of patients with metastatic bone disease (MBD), this comprehensive text combines discussion of the pathobiology of the disease with the latest oncological and orthopedic treatment modalities. After opening with an examination of the epidemiology and impact of MBD, the biology of bone metastases are discussed, along with considerations of the tissue of origin. Evaluation, biopsy and medical therapy, including metabolic agents and biotargeting. The heart of the book presents oncological approaches (supportive, radiation, and interventional) and principles of orthopedic surgical oncology, with subsequent chapters covering specific anatomy, from the pelvis to the lower extremity and the spine. Chapters on emerging surgical technology and future directions conclude the text and redefine an integrated approach to patient care. Taken together, Metastatic Bone Disease is an excellent resource for orthopedic surgeons and cancer specialists alike.
- Contents
- Part I. The Problem -- Bone Metastases: Epidemiology and Societal Effect -- Part II. Biology of Metastases and Tissue of Origin Considerations -- Pathobiology of Osteolytic and Osteoblastic Bone Metastases -- Biology of Bone Cancer Pain -- Breast Cancer Bone Metastases -- Prostate Cancer Bone Metastasis -- Lung -- Kidney Metastatic Bone Disease -- Thyroid -- Myeloma -- Part III. Work-Up for Patients with Suspected Metastatic Bone Disease -- Evaluation of the Patient with Carcinoma of Unknown Origin Metastatic to Bone -- Biopsy Considerations -- Part IV. Medical Therapy -- Bisphosphonates, Denosumab and Anabolic Agents in the Treatment of Metastatic Bone Disease -- Biotargeting in Metastatic Bone Disease -- Part V. Supportive Oncology -- Psychosocial Considerations for Patients with Metastatic Bone Disease -- Pain Management in Metastatic Bone Disease -- When is Hospice Appropriate? The Role for Hospice in Palliating Patients with Bone Metastases -- Part VI. Radiation Oncology -- Current and Emerging Modalities -- Part VII. Interventional Oncology -- Ablation and Cementation Technologies -- Part VIII. Principles of Orthopaedic Surgical Oncology -- Issues Facing the Established Metastatic Bone Disease Patient, Timing/Indications for Surgery -- Questions to Ask Your Medical Oncology Colleagues -- Consideration of the Temporal Relationship between Surgery and Radiation Therapy -- Role of Surgery in Oligometastatic Disease -- Part IX. Specific Anatomic Considerations for Surgery -- Metastatic Bone Disease: Pelvis -- Metastatic Bone Disease: Femur -- Metastatic Bone Disease: Femur: Tibia -- Metastatic Bone Disease: Foot -- Metastatic Bone Disease: Femur: Humerus, Scapula -- Metastatic Bone Disease: Forearm, Hand -- Metastatic Bone Disease: Spine -- Part X. Emerging Surgical Technologies -- Intraoperative Imaging and Navigation -- Part Eleven: Putting It All Together -- Integrative Approach with the Patient in Mind: A Glance Forward.
- Format
- e-Book
- Location
- Online
